0001140361-24-024332.txt : 20240503
0001140361-24-024332.hdr.sgml : 20240503
20240503160605
ACCESSION NUMBER: 0001140361-24-024332
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240501
FILED AS OF DATE: 20240503
DATE AS OF CHANGE: 20240503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILMAN STEVEN C
CENTRAL INDEX KEY: 0001379970
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 24913033
MAIL ADDRESS:
STREET 1: 110 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
form4.xml
FORM 4
X0508
4
2024-05-01
0000887359
Vericel Corp
VCEL
0001379970
GILMAN STEVEN C
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
true
false
Common Stock
2024-05-01
4
M
0
3200
A
11000
D
Restricted Stock Unit
2024-05-01
4
M
0
3200
0
A
Common Stock
3200
0
D
Stock Option (Right to Buy)
47.08
2024-05-01
4
A
0
8000
0
A
2034-05-01
Common Stock
8000
8000
D
Restricted Stock Unit
2024-05-01
4
A
0
3200
0
A
Common Stock
3200
3200
D
The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on May 3, 2023.
Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
These RSUs vest 100% on the earlier of May 3, 2024, or the date of the first Annual Meeting of Stockholders following May 3, 2023.
No expiration date for this type of award.
The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024.
/s/ Sean Flynn, as Attorney-in-Fact for Steven Gilman
2024-05-03